ISRAEL 
HIGH-TECH & INVESTMENT REPORT

from the February 2010 issue


Teva forecasts $31b sales by 2015

Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) senior managers have published its strategic plan for the next five years.

The company expects that By 2015, its sales will reach $31 billion with a profit of $6.8b. billion.

In the previous plan, presented in 2008, the goal was 20/20 sales of $20 billion and a net profit margin of over 20% of sales in 2012.

Israel is considered the Silicon Valley of water technology, and exporting high-tech innovations in this area played a role in helping the country rebound before most other nations from the world's worst recession in decades. Drip irrigation, desalination, conservation, wastewater management and recycling are all technologies where Israel is well ahead of the game.



Reprinted from the Israel High-Tech & Investment Report February 2010

Click HERE to request further information.
Click HERE to go BACK.